Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| §102 only | 1 (17%) |
| §112 only | 1 (17%) |
| No statute on record | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| THUESON, HANNA MARIE | 1 | 71.4% | +30.8% |
| WRIGHT, ERIC BRANDON | 1 | — | — |
| YU, DELPHINUS DOU YI | 1 | 0.0% | +0.0% |
| AMICK, THOMAS RUSSE | 1 | 73.3% | +30.5% |
| PRONZATI, GINA | 1 | 66.7% | +41.7% |
| SCHWECHTER, BRANDON ROSS | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18457605 | GENE SILENCING THERAPY OF ACUTE RESPIRATORY DISORDER | YU, DELPHINUS DOU YI | 79d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18410531 | PREDICTION OF STEM CELL THERAPY RESPONSIVENESS BY QUANTIFICATION OF PRE-EXISTING B REGULATORY CELLS | THUESON, HANNA MARIE | 32d overdue |
| 18449657 | TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY MESENCHYMAL STEM CELL APOPTOTIC BODIES AND COMPOSITIONS THEREOF | AMICK, THOMAS RUSSE | 15d overdue |
| 18361712 | GENE MODIFIED IPSC DERIVED CELLULAR COMPOSITIONS FOR REGENERATION AND IMMUNE MODULATION | PRONZATI, GINA | 11d overdue |
| Art Unit | Apps |
|---|---|
| 1638 | 2 |
| 1632 | 1 |
| 1636 | 1 |
| 1633 | 1 |
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18410531 | PREDICTION OF STEM CELL THERAPY RESPONSIVENESS BY QUANTIFICATION OF PRE-EXISTING B REGULATORY CELLS | THUESON, HANNA MARIE | 1638 | §102 | Non-Final OA | 32d overdue | Pending | Jan 11, 2024 |
| 18508623 | TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MYELOID DERIVED SUPPRESSOR CELLS | WRIGHT, ERIC BRANDON | 1632 | Other | Non-Final OA | 4d overdue | Pending | Nov 14, 2023 |
| 18457605 | GENE SILENCING THERAPY OF ACUTE RESPIRATORY DISORDER | YU, DELPHINUS DOU YI | 1636 | §112 | Non-Final OA | 79d overdue | Pending | Aug 29, 2023 |
| 18449657 | TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY MESENCHYMAL STEM CELL APOPTOTIC BODIES AND COMPOSITIONS THEREOF | AMICK, THOMAS RUSSE | 1638 | §103 | Non-Final OA | 15d overdue | Pending | Aug 14, 2023 |
| 18361712 | GENE MODIFIED IPSC DERIVED CELLULAR COMPOSITIONS FOR REGENERATION AND IMMUNE MODULATION | PRONZATI, GINA | 1633 | Other | Non-Final OA | 11d overdue | Pending | Jul 28, 2023 |
| 18316084 | INHIBITION AND REVERSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY ENDOTHELIAL CELL REGENERATION | SCHWECHTER, BRANDON ROSS | 1674 | §103 | Non-Final OA | 28d overdue | Pending | May 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial